

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glucocorticoid biosynthetic process (GO:0006704) | 7.89301172 |
| 2 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 6.71555689 |
| 3 | C21-steroid hormone biosynthetic process (GO:0006700) | 6.30549950 |
| 4 | glucocorticoid metabolic process (GO:0008211) | 6.26702753 |
| 5 | surfactant homeostasis (GO:0043129) | 6.04257675 |
| 6 | blood vessel maturation (GO:0001955) | 5.83745150 |
| 7 | response to follicle-stimulating hormone (GO:0032354) | 5.61631527 |
| 8 | androgen biosynthetic process (GO:0006702) | 5.51734469 |
| 9 | cellular response to antibiotic (GO:0071236) | 5.48480431 |
| 10 | progesterone metabolic process (GO:0042448) | 5.40535559 |
| 11 | regulation of endothelial cell differentiation (GO:0045601) | 5.08447087 |
| 12 | cellular response to epinephrine stimulus (GO:0071872) | 4.85443852 |
| 13 | chemical homeostasis within a tissue (GO:0048875) | 4.71724068 |
| 14 | positive regulation of vasculogenesis (GO:2001214) | 4.69736914 |
| 15 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.69232714 |
| 16 | estrogen biosynthetic process (GO:0006703) | 4.64342313 |
| 17 | basement membrane organization (GO:0071711) | 4.63000108 |
| 18 | endothelial tube morphogenesis (GO:0061154) | 4.57774085 |
| 19 | morphogenesis of an endothelium (GO:0003159) | 4.57774085 |
| 20 | C21-steroid hormone metabolic process (GO:0008207) | 4.54682446 |
| 21 | lymphangiogenesis (GO:0001946) | 4.52378605 |
| 22 | regulation of vasculogenesis (GO:2001212) | 4.47439212 |
| 23 | cellular response to cadmium ion (GO:0071276) | 4.42546945 |
| 24 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.36806992 |
| 25 | cellular response to gonadotropin stimulus (GO:0071371) | 4.30615797 |
| 26 | response to epinephrine (GO:0071871) | 4.09511303 |
| 27 | endothelium development (GO:0003158) | 3.95057217 |
| 28 | complement activation, alternative pathway (GO:0006957) | 3.92218118 |
| 29 | cellular response to toxic substance (GO:0097237) | 3.88198316 |
| 30 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.86884207 |
| 31 | cellular response to growth hormone stimulus (GO:0071378) | 3.82105874 |
| 32 | response to insecticide (GO:0017085) | 3.82021728 |
| 33 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.79864405 |
| 34 | lymph vessel development (GO:0001945) | 3.79437891 |
| 35 | Leydig cell differentiation (GO:0033327) | 3.75592611 |
| 36 | regulation of complement activation (GO:0030449) | 3.72541609 |
| 37 | angiogenesis involved in wound healing (GO:0060055) | 3.70249309 |
| 38 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.65089387 |
| 39 | regulation of protein activation cascade (GO:2000257) | 3.64320126 |
| 40 | ovulation from ovarian follicle (GO:0001542) | 3.51905087 |
| 41 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.50637401 |
| 42 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.38668031 |
| 43 | sprouting angiogenesis (GO:0002040) | 3.37889962 |
| 44 | labyrinthine layer development (GO:0060711) | 3.35111808 |
| 45 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.34917910 |
| 46 | regulation of macrophage chemotaxis (GO:0010758) | 3.33252474 |
| 47 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.29631281 |
| 48 | negative regulation of fibrinolysis (GO:0051918) | 3.26160553 |
| 49 | mating behavior (GO:0007617) | 3.25500518 |
| 50 | endothelial cell differentiation (GO:0045446) | 3.21881761 |
| 51 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.17612107 |
| 52 | phospholipid efflux (GO:0033700) | 3.16211887 |
| 53 | response to gonadotropin (GO:0034698) | 3.14511492 |
| 54 | adhesion of symbiont to host (GO:0044406) | 3.12868896 |
| 55 | hormone biosynthetic process (GO:0042446) | 3.07406679 |
| 56 | apoptotic cell clearance (GO:0043277) | 3.01864974 |
| 57 | protein kinase C signaling (GO:0070528) | 3.00494363 |
| 58 | lung lobe morphogenesis (GO:0060463) | 3.00233987 |
| 59 | eosinophil chemotaxis (GO:0048245) | 2.99786302 |
| 60 | response to phenylpropanoid (GO:0080184) | 2.99064794 |
| 61 | low-density lipoprotein particle clearance (GO:0034383) | 2.98250951 |
| 62 | regulation of cholesterol storage (GO:0010885) | 2.97319899 |
| 63 | Notch signaling involved in heart development (GO:0061314) | 2.96954033 |
| 64 | patterning of blood vessels (GO:0001569) | 2.96428140 |
| 65 | gap junction assembly (GO:0016264) | 2.95823387 |
| 66 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.95116669 |
| 67 | blood vessel endothelial cell migration (GO:0043534) | 2.93280961 |
| 68 | endocrine hormone secretion (GO:0060986) | 2.92743634 |
| 69 | reverse cholesterol transport (GO:0043691) | 2.92732872 |
| 70 | keratan sulfate catabolic process (GO:0042340) | 2.92394856 |
| 71 | regulation of fibrinolysis (GO:0051917) | 2.89904417 |
| 72 | benzene-containing compound metabolic process (GO:0042537) | 2.89009288 |
| 73 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.88907863 |
| 74 | toxin metabolic process (GO:0009404) | 2.88036296 |
| 75 | phospholipid homeostasis (GO:0055091) | 2.87998979 |
| 76 | androgen metabolic process (GO:0008209) | 2.87018890 |
| 77 | regulation of cholesterol esterification (GO:0010872) | 2.86923893 |
| 78 | negative regulation of epithelial cell migration (GO:0010633) | 2.86756889 |
| 79 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.84970133 |
| 80 | response to methylmercury (GO:0051597) | 2.83440165 |
| 81 | high-density lipoprotein particle remodeling (GO:0034375) | 2.83001423 |
| 82 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.82691084 |
| 83 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.82576495 |
| 84 | negative regulation of platelet activation (GO:0010544) | 2.82456826 |
| 85 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.81500207 |
| 86 | plasma lipoprotein particle clearance (GO:0034381) | 2.81290625 |
| 87 | exocrine pancreas development (GO:0031017) | 2.81251495 |
| 88 | phagocytosis, recognition (GO:0006910) | 2.80870724 |
| 89 | response to vitamin E (GO:0033197) | 2.80765234 |
| 90 | regulation of blood vessel endothelial cell migration (GO:0043535) | 2.80716403 |
| 91 | endothelial cell morphogenesis (GO:0001886) | 2.80176453 |
| 92 | protein carboxylation (GO:0018214) | 2.79645107 |
| 93 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.79645107 |
| 94 | positive regulation of p38MAPK cascade (GO:1900745) | 2.79102724 |
| 95 | blood vessel remodeling (GO:0001974) | 2.78280014 |
| 96 | positive regulation of urine volume (GO:0035810) | 2.77523175 |
| 97 | negative regulation of angiogenesis (GO:0016525) | 2.77320927 |
| 98 | complement activation (GO:0006956) | 2.76683158 |
| 99 | positive regulation of receptor recycling (GO:0001921) | 2.74558567 |
| 100 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 2.71786148 |
| 101 | * hyaluronan catabolic process (GO:0030214) | 2.70494845 |
| 102 | axon extension involved in axon guidance (GO:0048846) | 2.69634224 |
| 103 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.69634224 |
| 104 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.69621145 |
| 105 | complement activation, classical pathway (GO:0006958) | 2.66154676 |
| 106 | negative regulation of blood vessel morphogenesis (GO:2000181) | 2.66053606 |
| 107 | hormone catabolic process (GO:0042447) | 2.64169808 |
| 108 | endothelial cell migration (GO:0043542) | 2.62481345 |
| 109 | growth hormone receptor signaling pathway (GO:0060396) | 2.62285294 |
| 110 | positive regulation of hormone metabolic process (GO:0032352) | 2.61911013 |
| 111 | pinocytosis (GO:0006907) | 2.61791679 |
| 112 | cellular response to catecholamine stimulus (GO:0071870) | 2.60731913 |
| 113 | cellular response to monoamine stimulus (GO:0071868) | 2.60731913 |
| 114 | ovulation (GO:0030728) | 2.60487916 |
| 115 | wound healing, spreading of epidermal cells (GO:0035313) | 2.60294241 |
| 116 | positive regulation of steroid metabolic process (GO:0045940) | 2.59789505 |
| 117 | renal filtration (GO:0097205) | 2.58342558 |
| 118 | transcytosis (GO:0045056) | 2.58007789 |
| 119 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.57686554 |
| 120 | vasculogenesis (GO:0001570) | 2.57552939 |
| 121 | lung vasculature development (GO:0060426) | 2.56508392 |
| 122 | eosinophil migration (GO:0072677) | 2.56174773 |
| 123 | endothelial cell proliferation (GO:0001935) | 2.55057574 |
| 124 | endothelial cell chemotaxis (GO:0035767) | 2.54896072 |
| 125 | protein localization to endosome (GO:0036010) | 2.54840230 |
| 126 | cellular response to dexamethasone stimulus (GO:0071549) | 2.54288379 |
| 127 | negative regulation of endothelial cell migration (GO:0010596) | 2.53768381 |
| 128 | venous blood vessel morphogenesis (GO:0048845) | 2.53151434 |
| 129 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.51575418 |
| 130 | heart trabecula formation (GO:0060347) | 2.51139750 |
| 131 | negative regulation of vascular permeability (GO:0043116) | 2.50919737 |
| 132 | negative regulation of complement activation (GO:0045916) | 2.50682793 |
| 133 | glomerular filtration (GO:0003094) | 2.50084520 |
| 134 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.49701000 |
| 135 | cholesterol efflux (GO:0033344) | 2.48899166 |
| 136 | positive regulation of protein kinase C signaling (GO:0090037) | 2.48793054 |
| 137 | regulation of endothelial cell migration (GO:0010594) | 2.48557351 |
| 138 | negative regulation of vasculature development (GO:1901343) | 2.48143311 |
| 139 | positive regulation of glomerulus development (GO:0090193) | 2.46858763 |
| 140 | positive regulation of sterol transport (GO:0032373) | 2.46124984 |
| 141 | positive regulation of cholesterol transport (GO:0032376) | 2.46124984 |
| 142 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.45658051 |
| 143 | endocrine process (GO:0050886) | 2.45658051 |
| 144 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.45658051 |
| 145 | sexual reproduction (GO:0019953) | 2.45598905 |
| 146 | protein activation cascade (GO:0072376) | 2.44367475 |
| 147 | negative regulation of hemostasis (GO:1900047) | 2.43835346 |
| 148 | negative regulation of blood coagulation (GO:0030195) | 2.43835346 |
| 149 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.43721167 |
| 150 | artery development (GO:0060840) | 2.43461915 |
| 151 | positive regulation of cholesterol efflux (GO:0010875) | 2.42988732 |
| 152 | negative regulation of fatty acid transport (GO:2000192) | 2.42597194 |
| 153 | intracellular lipid transport (GO:0032365) | 2.42319758 |
| 154 | peptide catabolic process (GO:0043171) | 2.42316137 |
| 155 | negative regulation of protein activation cascade (GO:2000258) | 2.41993876 |
| 156 | alpha-linolenic acid metabolic process (GO:0036109) | 2.41896403 |
| 157 | cAMP biosynthetic process (GO:0006171) | 2.40207007 |
| 158 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.40036415 |
| 159 | positive regulation of hemostasis (GO:1900048) | 2.40008209 |
| 160 | positive regulation of blood coagulation (GO:0030194) | 2.40008209 |
| 161 | detection of molecule of bacterial origin (GO:0032490) | 2.39462353 |
| 162 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.38731604 |
| 163 | opsonization (GO:0008228) | 2.38436635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.45620746 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.18913227 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.92683403 |
| 4 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.47635142 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.17708272 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.02766607 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.88893834 |
| 8 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.81128547 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.67066128 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.59232985 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.47946107 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.29896931 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.12904770 |
| 14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.08613413 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.03254684 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.92789394 |
| 17 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.80774014 |
| 18 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.73441410 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64491762 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.63965623 |
| 21 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.63920179 |
| 22 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.63123728 |
| 23 | GATA1_19941826_ChIP-Seq_K562_Human | 1.59582236 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.59066403 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.53650962 |
| 26 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.52408884 |
| 27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.51491708 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.45296929 |
| 29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.41859136 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.41709580 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.39444986 |
| 32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.37186846 |
| 33 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.36019379 |
| 34 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35419733 |
| 35 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.32008057 |
| 36 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.31131118 |
| 37 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31095270 |
| 38 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.28941054 |
| 39 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.28941054 |
| 40 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.27034923 |
| 41 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.25930079 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25612403 |
| 43 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.25160572 |
| 44 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.25105235 |
| 45 | CJUN_26792858_Chip-Seq_BT549_Human | 1.24029878 |
| 46 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.23621462 |
| 47 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19777280 |
| 48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.19552879 |
| 49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19485504 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.19232440 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19067235 |
| 52 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18499035 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17741363 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17610265 |
| 55 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17400918 |
| 56 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.16447747 |
| 57 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16019621 |
| 58 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.15214078 |
| 59 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.14072777 |
| 60 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.12881226 |
| 61 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07455472 |
| 62 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.07418374 |
| 63 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06539303 |
| 64 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.06533161 |
| 65 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.06317796 |
| 66 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.04883251 |
| 67 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03946771 |
| 68 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03410368 |
| 69 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.03015165 |
| 70 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.02880162 |
| 71 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02784665 |
| 72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.02715172 |
| 73 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01754190 |
| 74 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.99168184 |
| 75 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.96432938 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96343853 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94985330 |
| 78 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94947087 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94406601 |
| 80 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94076625 |
| 81 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93222555 |
| 82 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92843612 |
| 83 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.92153640 |
| 84 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.92153640 |
| 85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.92103284 |
| 86 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.91500582 |
| 87 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91364813 |
| 88 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90789676 |
| 89 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.90775985 |
| 90 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.90267681 |
| 91 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.89937670 |
| 92 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89682027 |
| 93 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.89511591 |
| 94 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.89179760 |
| 95 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.89145917 |
| 96 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.88724243 |
| 97 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.88009583 |
| 98 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87279381 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86736415 |
| 100 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.86686847 |
| 101 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.86118719 |
| 102 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85666260 |
| 103 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.85026513 |
| 104 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83341819 |
| 105 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.83339406 |
| 106 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.83324180 |
| 107 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83267356 |
| 108 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.83131863 |
| 109 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.83071821 |
| 110 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83061968 |
| 111 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81958347 |
| 112 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81958347 |
| 113 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.81497675 |
| 114 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80347188 |
| 115 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79526552 |
| 116 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.78687486 |
| 117 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.78167209 |
| 118 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77778723 |
| 119 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.77611740 |
| 120 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.77495194 |
| 121 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.77481518 |
| 122 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.77208550 |
| 123 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.76510089 |
| 124 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.76328280 |
| 125 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.74499442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0010368_abnormal_lymphatic_system | 5.61882183 |
| 2 | MP0004272_abnormal_basement_membrane | 4.31562871 |
| 3 | MP0005167_abnormal_blood-brain_barrier | 4.21462190 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 3.83815845 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 3.81137166 |
| 6 | * MP0001879_abnormal_lymphatic_vessel | 3.80655456 |
| 7 | MP0004782_abnormal_surfactant_physiolog | 3.11005418 |
| 8 | MP0009840_abnormal_foam_cell | 2.88783738 |
| 9 | MP0004510_myositis | 2.66022672 |
| 10 | MP0003011_delayed_dark_adaptation | 2.62653619 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.47096333 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.37501219 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.29594678 |
| 14 | MP0005360_urolithiasis | 2.22225319 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.19200559 |
| 16 | MP0003724_increased_susceptibility_to | 2.14774142 |
| 17 | MP0000343_altered_response_to | 2.07704648 |
| 18 | MP0004084_abnormal_cardiac_muscle | 2.06985291 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.05744436 |
| 20 | MP0003828_pulmonary_edema | 2.01716226 |
| 21 | MP0003566_abnormal_cell_adhesion | 2.00997263 |
| 22 | MP0002332_abnormal_exercise_endurance | 1.98445943 |
| 23 | MP0005409_darkened_coat_color | 1.97299786 |
| 24 | MP0004484_altered_response_of | 1.90173237 |
| 25 | MP0005365_abnormal_bile_salt | 1.81870299 |
| 26 | MP0000767_abnormal_smooth_muscle | 1.79527729 |
| 27 | MP0000639_abnormal_adrenal_gland | 1.79234504 |
| 28 | MP0002295_abnormal_pulmonary_circulatio | 1.78510281 |
| 29 | MP0001661_extended_life_span | 1.78166389 |
| 30 | MP0010329_abnormal_lipoprotein_level | 1.77085420 |
| 31 | MP0001958_emphysema | 1.76824986 |
| 32 | MP0005670_abnormal_white_adipose | 1.71932264 |
| 33 | MP0005165_increased_susceptibility_to | 1.71572937 |
| 34 | MP0003279_aneurysm | 1.69197297 |
| 35 | MP0002933_joint_inflammation | 1.67195716 |
| 36 | MP0005275_abnormal_skin_tensile | 1.65636297 |
| 37 | MP0005085_abnormal_gallbladder_physiolo | 1.63617756 |
| 38 | MP0004215_abnormal_myocardial_fiber | 1.59142895 |
| 39 | MP0000249_abnormal_blood_vessel | 1.57036403 |
| 40 | MP0003941_abnormal_skin_development | 1.53347580 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.52523697 |
| 42 | MP0004036_abnormal_muscle_relaxation | 1.51393770 |
| 43 | MP0005503_abnormal_tendon_morphology | 1.49382168 |
| 44 | MP0005595_abnormal_vascular_smooth | 1.48854183 |
| 45 | MP0000751_myopathy | 1.48285112 |
| 46 | MP0004883_abnormal_blood_vessel | 1.39313399 |
| 47 | MP0006138_congestive_heart_failure | 1.38774923 |
| 48 | MP0000003_abnormal_adipose_tissue | 1.35542520 |
| 49 | MP0005375_adipose_tissue_phenotype | 1.31510727 |
| 50 | MP0005164_abnormal_response_to | 1.30424211 |
| 51 | MP0003252_abnormal_bile_duct | 1.25909122 |
| 52 | MP0009764_decreased_sensitivity_to | 1.21902271 |
| 53 | MP0002254_reproductive_system_inflammat | 1.16358721 |
| 54 | MP0003091_abnormal_cell_migration | 1.15036885 |
| 55 | MP0003122_maternal_imprinting | 1.14648035 |
| 56 | MP0003303_peritoneal_inflammation | 1.12688610 |
| 57 | MP0006054_spinal_hemorrhage | 1.11919294 |
| 58 | MP0000013_abnormal_adipose_tissue | 1.11670431 |
| 59 | MP0009780_abnormal_chondrocyte_physiolo | 1.09926935 |
| 60 | MP0003075_altered_response_to | 1.08802058 |
| 61 | MP0000230_abnormal_systemic_arterial | 1.07161653 |
| 62 | MP0010630_abnormal_cardiac_muscle | 1.06549763 |
| 63 | MP0005330_cardiomyopathy | 1.06233445 |
| 64 | MP0002118_abnormal_lipid_homeostasis | 1.05180807 |
| 65 | MP0001544_abnormal_cardiovascular_syste | 1.04587143 |
| 66 | MP0005385_cardiovascular_system_phenoty | 1.04587143 |
| 67 | MP0005620_abnormal_muscle_contractility | 1.04397656 |
| 68 | MP0004264_abnormal_extraembryonic_tissu | 1.03522391 |
| 69 | MP0002837_dystrophic_cardiac_calcinosis | 1.02354915 |
| 70 | MP0005083_abnormal_biliary_tract | 1.01774308 |
| 71 | MP0000609_abnormal_liver_physiology | 1.01185962 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.00614502 |
| 73 | MP0002108_abnormal_muscle_morphology | 0.99901957 |
| 74 | MP0009643_abnormal_urine_homeostasis | 0.99421692 |
| 75 | MP0004087_abnormal_muscle_fiber | 0.99362532 |
| 76 | MP0004130_abnormal_muscle_cell | 0.98603020 |
| 77 | MP0005187_abnormal_penis_morphology | 0.98279432 |
| 78 | MP0000750_abnormal_muscle_regeneration | 0.96239823 |
| 79 | MP0008995_early_reproductive_senescence | 0.96115612 |
| 80 | MP0002971_abnormal_brown_adipose | 0.94225261 |
| 81 | * MP0002128_abnormal_blood_circulation | 0.93445394 |
| 82 | MP0001533_abnormal_skeleton_physiology | 0.92173593 |
| 83 | MP0003690_abnormal_glial_cell | 0.91313245 |
| 84 | MP0003436_decreased_susceptibility_to | 0.90563467 |
| 85 | MP0004085_abnormal_heartbeat | 0.89845930 |
| 86 | MP0001666_abnormal_nutrient_absorption | 0.86710108 |
| 87 | MP0002419_abnormal_innate_immunity | 0.86312832 |
| 88 | MP0001614_abnormal_blood_vessel | 0.85670213 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 0.85470264 |
| 90 | MP0004019_abnormal_vitamin_homeostasis | 0.83805682 |
| 91 | MP0003567_abnormal_fetal_cardiomyocyte | 0.83589397 |
| 92 | MP0001727_abnormal_embryo_implantation | 0.83544567 |
| 93 | MP0000604_amyloidosis | 0.82437469 |
| 94 | MP0001756_abnormal_urination | 0.82320405 |
| 95 | MP0000749_muscle_degeneration | 0.81730662 |
| 96 | MP0005388_respiratory_system_phenotype | 0.81598866 |
| 97 | MP0002133_abnormal_respiratory_system | 0.81598866 |
| 98 | MP0003950_abnormal_plasma_membrane | 0.79422112 |
| 99 | MP0009115_abnormal_fat_cell | 0.77641331 |
| 100 | MP0000747_muscle_weakness | 0.76819299 |
| 101 | MP0005319_abnormal_enzyme/_coenzyme | 0.75545438 |
| 102 | MP0005023_abnormal_wound_healing | 0.75054625 |
| 103 | MP0001915_intracranial_hemorrhage | 0.75032220 |
| 104 | MP0003300_gastrointestinal_ulcer | 0.74912536 |
| 105 | MP0003638_abnormal_response/metabolism_ | 0.74556282 |
| 106 | MP0002925_abnormal_cardiovascular_devel | 0.73531446 |
| 107 | MP0005666_abnormal_adipose_tissue | 0.73179998 |
| 108 | MP0005166_decreased_susceptibility_to | 0.72984384 |
| 109 | MP0002148_abnormal_hypersensitivity_rea | 0.72771232 |
| 110 | MP0008469_abnormal_protein_level | 0.72549725 |
| 111 | MP0000266_abnormal_heart_morphology | 0.72164613 |
| 112 | MP0002269_muscular_atrophy | 0.71559990 |
| 113 | MP0002127_abnormal_cardiovascular_syste | 0.71432591 |
| 114 | MP0002106_abnormal_muscle_physiology | 0.71030725 |
| 115 | MP0002896_abnormal_bone_mineralization | 0.69263986 |
| 116 | MP0005332_abnormal_amino_acid | 0.69083283 |
| 117 | MP0003948_abnormal_gas_homeostasis | 0.69042169 |
| 118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68626274 |
| 119 | MP0002998_abnormal_bone_remodeling | 0.64925061 |
| 120 | MP0005508_abnormal_skeleton_morphology | 0.64228292 |
| 121 | MP0003959_abnormal_lean_body | 0.63834751 |
| 122 | MP0002909_abnormal_adrenal_gland | 0.63687365 |
| 123 | MP0005369_muscle_phenotype | 0.63584239 |
| 124 | MP0008775_abnormal_heart_ventricle | 0.61993801 |
| 125 | MP0002972_abnormal_cardiac_muscle | 0.61096738 |
| 126 | MP0003045_fibrosis | 0.60283885 |
| 127 | MP0008004_abnormal_stomach_pH | 0.60247511 |
| 128 | MP0001175_abnormal_lung_morphology | 0.59921337 |
| 129 | MP0001784_abnormal_fluid_regulation | 0.59474990 |
| 130 | MP0005334_abnormal_fat_pad | 0.59111073 |
| 131 | MP0001790_abnormal_immune_system | 0.58847995 |
| 132 | MP0005387_immune_system_phenotype | 0.58847995 |
| 133 | MP0009697_abnormal_copulation | 0.58642909 |
| 134 | MP0002877_abnormal_melanocyte_morpholog | 0.58482036 |
| 135 | MP0003868_abnormal_feces_composition | 0.57568622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Spontaneous hematomas (HP:0007420) | 7.12854286 |
| 2 | Hematochezia (HP:0002573) | 6.36559387 |
| 3 | Polycythemia (HP:0001901) | 5.98700538 |
| 4 | Complement deficiency (HP:0004431) | 5.92316436 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 5.64604175 |
| 6 | Renal salt wasting (HP:0000127) | 4.79261263 |
| 7 | Deep venous thrombosis (HP:0002625) | 4.73028528 |
| 8 | Conjunctival telangiectasia (HP:0000524) | 4.68863193 |
| 9 | Abnormality of complement system (HP:0005339) | 4.68474114 |
| 10 | Cerebral aneurysm (HP:0004944) | 4.63007914 |
| 11 | Esophageal varix (HP:0002040) | 4.18131910 |
| 12 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 4.16792332 |
| 13 | Abnormality of the nasal mucosa (HP:0000433) | 4.07614912 |
| 14 | Glomerulonephritis (HP:0000099) | 4.01146828 |
| 15 | Cerebral hemorrhage (HP:0001342) | 3.82219056 |
| 16 | Asymmetry of the thorax (HP:0001555) | 3.80820182 |
| 17 | Protrusio acetabuli (HP:0003179) | 3.70964265 |
| 18 | Interstitial pulmonary disease (HP:0006530) | 3.61316285 |
| 19 | Joint hemorrhage (HP:0005261) | 3.53275754 |
| 20 | Hyperaldosteronism (HP:0000859) | 3.27259544 |
| 21 | Visceral angiomatosis (HP:0100761) | 3.24763785 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.15216269 |
| 23 | Hemorrhage of the eye (HP:0011885) | 3.13894686 |
| 24 | Hyporeflexia of lower limbs (HP:0002600) | 3.11925525 |
| 25 | Difficulty running (HP:0009046) | 3.02431087 |
| 26 | Skull defect (HP:0001362) | 2.99668572 |
| 27 | Nephritis (HP:0000123) | 2.97292779 |
| 28 | Hemangiomatosis (HP:0007461) | 2.95449896 |
| 29 | Dysostosis multiplex (HP:0000943) | 2.92758533 |
| 30 | Mucosal telangiectasiae (HP:0100579) | 2.88484749 |
| 31 | Abnormal sex determination (HP:0012244) | 2.88338706 |
| 32 | Sex reversal (HP:0012245) | 2.88338706 |
| 33 | Xanthomatosis (HP:0000991) | 2.84079173 |
| 34 | Increased variability in muscle fiber diameter (HP:0003557) | 2.83954979 |
| 35 | Tetraparesis (HP:0002273) | 2.79066855 |
| 36 | Enlarged penis (HP:0000040) | 2.78296016 |
| 37 | Abnormality of the common coagulation pathway (HP:0010990) | 2.77741766 |
| 38 | Neurofibrillary tangles (HP:0002185) | 2.68615884 |
| 39 | Hemiplegia (HP:0002301) | 2.66810319 |
| 40 | Lymphangioma (HP:0100764) | 2.65739108 |
| 41 | Wrist flexion contracture (HP:0001239) | 2.62049364 |
| 42 | Amyloidosis (HP:0011034) | 2.58532463 |
| 43 | Hyperactive renin-angiotensin system (HP:0000841) | 2.58055738 |
| 44 | Absent hand (HP:0004050) | 2.57340038 |
| 45 | Stroke (HP:0001297) | 2.55063668 |
| 46 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.53091033 |
| 47 | Nonimmune hydrops fetalis (HP:0001790) | 2.49723552 |
| 48 | Cavernous hemangioma (HP:0001048) | 2.48452752 |
| 49 | Growth hormone excess (HP:0000845) | 2.46996551 |
| 50 | Overgrowth (HP:0001548) | 2.46817327 |
| 51 | Eczematoid dermatitis (HP:0000976) | 2.43210811 |
| 52 | Hypoglycemic coma (HP:0001325) | 2.43172183 |
| 53 | Abnormality of the intrinsic pathway (HP:0010989) | 2.34401589 |
| 54 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.33491495 |
| 55 | Osteolytic defects of the hand bones (HP:0009699) | 2.33491495 |
| 56 | Spinal rigidity (HP:0003306) | 2.32986446 |
| 57 | Hypoalphalipoproteinemia (HP:0003233) | 2.31451153 |
| 58 | Cerebral palsy (HP:0100021) | 2.31272911 |
| 59 | Arterial tortuosity (HP:0005116) | 2.30916619 |
| 60 | Adrenal overactivity (HP:0002717) | 2.30115601 |
| 61 | Aneurysm (HP:0002617) | 2.27761691 |
| 62 | Asymmetric septal hypertrophy (HP:0001670) | 2.27463637 |
| 63 | Pulmonary embolism (HP:0002204) | 2.26790598 |
| 64 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.25818249 |
| 65 | Mucopolysacchariduria (HP:0008155) | 2.25818249 |
| 66 | Microcytic anemia (HP:0001935) | 2.23976588 |
| 67 | Cerebral inclusion bodies (HP:0100314) | 2.23540082 |
| 68 | Increased cerebral lipofuscin (HP:0011813) | 2.20822847 |
| 69 | Absent eyebrow (HP:0002223) | 2.20274795 |
| 70 | Facial shape deformation (HP:0011334) | 2.19120466 |
| 71 | Potter facies (HP:0002009) | 2.19120466 |
| 72 | Aortic aneurysm (HP:0004942) | 2.18600401 |
| 73 | Limited hip movement (HP:0008800) | 2.18022474 |
| 74 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.16315051 |
| 75 | Vascular tortuosity (HP:0004948) | 2.14354578 |
| 76 | Right ventricular cardiomyopathy (HP:0011663) | 2.14052365 |
| 77 | Portal hypertension (HP:0001409) | 2.14023445 |
| 78 | Hip contracture (HP:0003273) | 2.12198437 |
| 79 | Mitral stenosis (HP:0001718) | 2.11582953 |
| 80 | Testicular neoplasm (HP:0010788) | 2.11522588 |
| 81 | Premature rupture of membranes (HP:0001788) | 2.11470337 |
| 82 | Atrioventricular block (HP:0001678) | 2.11439859 |
| 83 | Prolonged partial thromboplastin time (HP:0003645) | 2.11438435 |
| 84 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.11313818 |
| 85 | Adactyly (HP:0009776) | 2.11099107 |
| 86 | Hypoplasia of the iris (HP:0007676) | 2.11020696 |
| 87 | Wormian bones (HP:0002645) | 2.09315198 |
| 88 | Myotonia (HP:0002486) | 2.08735593 |
| 89 | Accelerated skeletal maturation (HP:0005616) | 2.08561324 |
| 90 | Distal arthrogryposis (HP:0005684) | 2.07577160 |
| 91 | Difficulty climbing stairs (HP:0003551) | 2.06888062 |
| 92 | Intrahepatic cholestasis (HP:0001406) | 2.06314515 |
| 93 | Distal lower limb muscle weakness (HP:0009053) | 2.06219145 |
| 94 | Thrombophlebitis (HP:0004418) | 2.05454274 |
| 95 | Hyperkalemia (HP:0002153) | 2.05338681 |
| 96 | Myocardial infarction (HP:0001658) | 2.04338415 |
| 97 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.02601682 |
| 98 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.02601682 |
| 99 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.02601682 |
| 100 | Abnormal atrioventricular conduction (HP:0005150) | 2.02067207 |
| 101 | Round ear (HP:0100830) | 2.00645866 |
| 102 | Neonatal death (HP:0003811) | 2.00627976 |
| 103 | Vacuolated lymphocytes (HP:0001922) | 2.00488655 |
| 104 | Pulmonary hypertension (HP:0002092) | 2.00451255 |
| 105 | Atrial fibrillation (HP:0005110) | 1.99962495 |
| 106 | Skin nodule (HP:0200036) | 1.97684487 |
| 107 | Sudden death (HP:0001699) | 1.97611887 |
| 108 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.96118010 |
| 109 | Decreased circulating renin level (HP:0003351) | 1.95534543 |
| 110 | Supraventricular arrhythmia (HP:0005115) | 1.95445225 |
| 111 | Oligomenorrhea (HP:0000876) | 1.95056250 |
| 112 | Heart block (HP:0012722) | 1.94824478 |
| 113 | Aortic dissection (HP:0002647) | 1.93302522 |
| 114 | Broad metatarsal (HP:0001783) | 1.91924242 |
| 115 | Hypokalemic alkalosis (HP:0001949) | 1.91526025 |
| 116 | Tubulointerstitial fibrosis (HP:0005576) | 1.91456532 |
| 117 | Epistaxis (HP:0000421) | 1.91383527 |
| 118 | Disproportionate tall stature (HP:0001519) | 1.91142226 |
| 119 | Capillary hemangiomas (HP:0005306) | 1.90386557 |
| 120 | Hyperlipoproteinemia (HP:0010980) | 1.86705405 |
| 121 | Mitral valve prolapse (HP:0001634) | 1.84942722 |
| 122 | Abnormality of the hepatic vasculature (HP:0006707) | 1.83552510 |
| 123 | Absent eyelashes (HP:0000561) | 1.82487798 |
| 124 | Tachypnea (HP:0002789) | 1.79216274 |
| 125 | Porencephaly (HP:0002132) | 1.78956210 |
| 126 | Recurrent abscess formation (HP:0002722) | 1.77527753 |
| 127 | Venous insufficiency (HP:0005293) | 1.77329032 |
| 128 | Axonal loss (HP:0003447) | 1.76948652 |
| 129 | Muscle fiber splitting (HP:0003555) | 1.76856862 |
| 130 | Dilatation of the ascending aorta (HP:0005111) | 1.75355768 |
| 131 | Primary atrial arrhythmia (HP:0001692) | 1.74958638 |
| 132 | Pustule (HP:0200039) | 1.74444059 |
| 133 | Recurrent bacterial skin infections (HP:0005406) | 1.73818625 |
| 134 | Venous abnormality (HP:0002624) | 1.73392459 |
| 135 | Joint stiffness (HP:0001387) | 1.73274054 |
| 136 | Menorrhagia (HP:0000132) | 1.71105643 |
| 137 | Increased connective tissue (HP:0009025) | 1.67087890 |
| 138 | Long toe (HP:0010511) | 1.66937499 |
| 139 | Hypercholesterolemia (HP:0003124) | 1.64561293 |
| 140 | Chronic bronchitis (HP:0004469) | 1.62523843 |
| 141 | Pulmonary artery stenosis (HP:0004415) | 1.62469248 |
| 142 | Striae distensae (HP:0001065) | 1.59156565 |
| 143 | Exotropia (HP:0000577) | 1.58249256 |
| 144 | Thick nail (HP:0001805) | 1.57000953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 5.77088058 |
| 2 | KDR | 3.92887497 |
| 3 | ERN1 | 2.71124890 |
| 4 | AKT3 | 2.44983878 |
| 5 | PTK2B | 2.02532028 |
| 6 | TIE1 | 10.3850018 |
| 7 | EPHB1 | 1.89298605 |
| 8 | GRK7 | 1.89133416 |
| 9 | TGFBR1 | 1.81142950 |
| 10 | TYK2 | 1.77784308 |
| 11 | EPHB2 | 1.75885830 |
| 12 | RIPK1 | 1.70393093 |
| 13 | TRIB3 | 1.66259579 |
| 14 | FGFR4 | 1.61157610 |
| 15 | GRK1 | 1.50713829 |
| 16 | PTK6 | 1.47159188 |
| 17 | DDR2 | 1.35400601 |
| 18 | MAP2K3 | 1.34890778 |
| 19 | TTN | 1.32536704 |
| 20 | FER | 1.30581850 |
| 21 | MET | 1.26573594 |
| 22 | STK10 | 1.25596335 |
| 23 | BLK | 1.25228456 |
| 24 | MAP3K3 | 1.22534016 |
| 25 | CSK | 1.16511426 |
| 26 | PRKG2 | 1.08367918 |
| 27 | MYLK | 1.07105838 |
| 28 | INSRR | 1.04928002 |
| 29 | EPHA3 | 1.01898031 |
| 30 | PDGFRA | 0.94490086 |
| 31 | CAMK1D | 0.94144959 |
| 32 | PTK2 | 0.93051722 |
| 33 | TRPM7 | 0.92959151 |
| 34 | PAK4 | 0.90257736 |
| 35 | OBSCN | 0.88131703 |
| 36 | GRK5 | 0.87442063 |
| 37 | MAP3K6 | 0.85509364 |
| 38 | SIK1 | 0.84890228 |
| 39 | EEF2K | 0.84028368 |
| 40 | MAP3K13 | 0.82572224 |
| 41 | PKN2 | 0.81149881 |
| 42 | MAPK7 | 0.77750472 |
| 43 | NLK | 0.76933027 |
| 44 | JAK1 | 0.76401344 |
| 45 | ZAP70 | 0.75996461 |
| 46 | DMPK | 0.74880537 |
| 47 | TBK1 | 0.73686986 |
| 48 | TESK1 | 0.72279193 |
| 49 | LRRK2 | 0.70878800 |
| 50 | MOS | 0.69468339 |
| 51 | MAP3K7 | 0.68015154 |
| 52 | ICK | 0.67446138 |
| 53 | PRKD1 | 0.67419724 |
| 54 | BMX | 0.67265032 |
| 55 | FGFR3 | 0.66988988 |
| 56 | TEC | 0.66210720 |
| 57 | MAP3K1 | 0.65039430 |
| 58 | BCKDK | 0.64380418 |
| 59 | MARK2 | 0.62629821 |
| 60 | JAK2 | 0.60703083 |
| 61 | MAPK12 | 0.60664312 |
| 62 | CAMK1G | 0.60248165 |
| 63 | ROCK2 | 0.60230874 |
| 64 | TAOK3 | 0.60031552 |
| 65 | FES | 0.59942239 |
| 66 | MAPKAPK3 | 0.59376963 |
| 67 | MST1R | 0.59088536 |
| 68 | EGFR | 0.59031220 |
| 69 | NTRK1 | 0.59002623 |
| 70 | FGFR2 | 0.58921723 |
| 71 | LATS2 | 0.58311104 |
| 72 | PRKAA2 | 0.57785251 |
| 73 | MAPK15 | 0.56529479 |
| 74 | PDGFRB | 0.55984370 |
| 75 | LMTK2 | 0.55879982 |
| 76 | CDC42BPA | 0.54662095 |
| 77 | AKT2 | 0.54033636 |
| 78 | GSK3A | 0.53613440 |
| 79 | KSR2 | 0.52522533 |
| 80 | SCYL2 | 0.52249796 |
| 81 | MAP3K2 | 0.51695992 |
| 82 | NEK9 | 0.49448019 |
| 83 | MAP4K1 | 0.48855317 |
| 84 | CLK1 | 0.48771799 |
| 85 | IGF1R | 0.48533238 |
| 86 | SGK2 | 0.48149050 |
| 87 | MAPK4 | 0.47810805 |
| 88 | MAP3K11 | 0.47336745 |
| 89 | MARK3 | 0.46892000 |
| 90 | PRKD2 | 0.46115648 |
| 91 | PHKG2 | 0.45124698 |
| 92 | PHKG1 | 0.45124698 |
| 93 | MAP2K2 | 0.45071689 |
| 94 | MAP3K10 | 0.44859672 |
| 95 | RET | 0.43963531 |
| 96 | RPS6KA2 | 0.43589477 |
| 97 | SGK3 | 0.43314920 |
| 98 | FGR | 0.42456865 |
| 99 | ARAF | 0.39806435 |
| 100 | SRC | 0.39305595 |
| 101 | SGK223 | 0.38600245 |
| 102 | SGK494 | 0.38600245 |
| 103 | PRKCH | 0.37023640 |
| 104 | HCK | 0.36670408 |
| 105 | CSF1R | 0.36400999 |
| 106 | MAP3K14 | 0.35151854 |
| 107 | DAPK2 | 0.34459036 |
| 108 | PDPK1 | 0.34400306 |
| 109 | YES1 | 0.34196984 |
| 110 | PDK1 | 0.31275970 |
| 111 | CAMK1 | 0.30824217 |
| 112 | PRPF4B | 0.30744872 |
| 113 | JAK3 | 0.30729215 |
| 114 | HIPK2 | 0.30095896 |
| 115 | FLT3 | 0.29910264 |
| 116 | CAMK4 | 0.29759398 |
| 117 | PRKD3 | 0.29387614 |
| 118 | ABL2 | 0.28934683 |
| 119 | MTOR | 0.28603063 |
| 120 | PRKAA1 | 0.28319333 |
| 121 | IRAK3 | 0.28047218 |
| 122 | ITK | 0.28038736 |
| 123 | MAP2K1 | 0.26895939 |
| 124 | PKN1 | 0.26825050 |
| 125 | PIK3CG | 0.26244323 |
| 126 | ILK | 0.26196651 |
| 127 | PAK2 | 0.25407974 |
| 128 | PRKCE | 0.24872095 |
| 129 | FGFR1 | 0.24364336 |
| 130 | LATS1 | 0.23791870 |
| 131 | IKBKE | 0.23059066 |
| 132 | CDK6 | 0.22844701 |
| 133 | ROCK1 | 0.21185411 |
| 134 | PRKACG | 0.20624131 |
| 135 | INSR | 0.19395401 |
| 136 | PRKACB | 0.17649099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.59901454 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.51600690 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.56250150 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.23000210 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.20228541 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.11522821 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.04725022 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.85483776 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.78926586 |
| 10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74046092 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.66719103 |
| 12 | Lysosome_Homo sapiens_hsa04142 | 1.65256222 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.64548311 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.56417693 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.48885447 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.44829742 |
| 17 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.38261474 |
| 18 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.34185246 |
| 19 | Prion diseases_Homo sapiens_hsa05020 | 1.33402056 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.32000859 |
| 21 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.28841465 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.28646388 |
| 23 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.28287815 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.24213924 |
| 25 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.20873586 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.17607844 |
| 27 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16701083 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.16065508 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.15916603 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.13448023 |
| 31 | ABC transporters_Homo sapiens_hsa02010 | 1.12212598 |
| 32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09909169 |
| 33 | Focal adhesion_Homo sapiens_hsa04510 | 1.08172284 |
| 34 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06759814 |
| 35 | Renin secretion_Homo sapiens_hsa04924 | 1.05362022 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.01852261 |
| 37 | Amoebiasis_Homo sapiens_hsa05146 | 1.01775030 |
| 38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.00988429 |
| 39 | Platelet activation_Homo sapiens_hsa04611 | 0.92026423 |
| 40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.91278604 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 0.90949634 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.88760845 |
| 43 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.87117996 |
| 44 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.86862057 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 0.86254010 |
| 46 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.85896152 |
| 47 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84256822 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84055285 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83781399 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.82449344 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80270713 |
| 52 | Phagosome_Homo sapiens_hsa04145 | 0.79886961 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77681574 |
| 54 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.77292491 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75568957 |
| 56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.75349973 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.73629465 |
| 58 | Insulin resistance_Homo sapiens_hsa04931 | 0.73463555 |
| 59 | Malaria_Homo sapiens_hsa05144 | 0.71868718 |
| 60 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.71506282 |
| 61 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70971370 |
| 62 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.70060828 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70046604 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.69593576 |
| 65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.68848370 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.67933718 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67683870 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67674513 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 0.66806327 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64164692 |
| 71 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.63746366 |
| 72 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.63010474 |
| 73 | Tight junction_Homo sapiens_hsa04530 | 0.62926642 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62160194 |
| 75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59529160 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59426193 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58235313 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57467803 |
| 79 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.56829406 |
| 80 | Gap junction_Homo sapiens_hsa04540 | 0.56226291 |
| 81 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.55961498 |
| 82 | Axon guidance_Homo sapiens_hsa04360 | 0.54927364 |
| 83 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.54630648 |
| 84 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54093559 |
| 85 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.53648154 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53179239 |
| 87 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.53083010 |
| 88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.51531968 |
| 89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50925351 |
| 90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.50912550 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49556699 |
| 92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49358561 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48800893 |
| 94 | Salmonella infection_Homo sapiens_hsa05132 | 0.48561224 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48334444 |
| 96 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47429756 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46882848 |
| 98 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46415157 |
| 99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46308320 |
| 100 | Leishmaniasis_Homo sapiens_hsa05140 | 0.45840995 |
| 101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45486566 |
| 102 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.45298754 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45196216 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45018413 |
| 105 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.44320352 |
| 106 | Lysine degradation_Homo sapiens_hsa00310 | 0.44198298 |
| 107 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44035525 |
| 108 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.43904810 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42052427 |
| 110 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.40873296 |
| 111 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.40750521 |
| 112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40365245 |
| 113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40265462 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.39400497 |
| 115 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.39387201 |
| 116 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.39052792 |
| 117 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.38378937 |
| 118 | Viral myocarditis_Homo sapiens_hsa05416 | 0.37817100 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37713388 |
| 120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37089620 |
| 121 | Tuberculosis_Homo sapiens_hsa05152 | 0.36971097 |
| 122 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.36406963 |
| 123 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36203918 |
| 124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34658009 |
| 125 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.34486887 |
| 126 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.34342095 |
| 127 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34178990 |
| 128 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34048018 |
| 129 | Mineral absorption_Homo sapiens_hsa04978 | 0.33960596 |
| 130 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32628963 |

